Source:http://linkedlifedata.com/resource/pubmed/id/20305341
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2010-3-22
|
pubmed:abstractText |
The present study evaluates the protein expression of estrogen receptor alpha (ERalpha), estrogen receptor beta (ERbeta), progesterone receptor (PR) and cKIT in a wide number of desmoids tumors and their role in determining treatment options. Fifty-nine cases classified as muscle aponeurotic fibromatosis were selected. Samples were grouped by tumor location in: head and neck, extremity and abdominal/trunk; type of resection of the primary tumor (complete resection with adequate margins, marginal resection and resection with inadequate margins); type of treatment (exclusive surgery, surgery followed by radiation therapy and surgery followed by tamoxifen or cyclooxygenase inhibitor). A tissue microarray (TMA) was built and the immunohistochemical reactions were performed against ERalpha, ERbeta, PR, and c-kit. All cases were negative for ERalpha, PR and c-KIT. 53/59 cases were positive for ERbeta. No significant difference was observed among clinical variables and the ERbeta status. The estimated 5 and 10 year local recurrence free survival (LRFS) for the patients with complete or marginal resection was 75% and 75%, respectively. Tumor location (p = 0.006) and type of resection (p = 0.001) were predictive of local relapse in the univariate analysis. All patients treated with post-operative tamoxifen were LRFS (p = 0.035). Head and neck and extremities lesions showed higher recurrence rates compared to abdominal/trunk lesions. Marginal resection was associated with local recurrence. In conclusion, although this is a retrospective study, the results presented can contribute to better understanding of the mechanisms under desmoid tumor development and can propose tamoxifen as a therapeutic option to be tested in prospective trials.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Receptor alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Receptor beta,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-kit,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1881-7823
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
25-30
|
pubmed:meshHeading |
pubmed-meshheading:20305341-Adult,
pubmed-meshheading:20305341-Estrogen Receptor alpha,
pubmed-meshheading:20305341-Estrogen Receptor beta,
pubmed-meshheading:20305341-Female,
pubmed-meshheading:20305341-Fibromatosis, Aggressive,
pubmed-meshheading:20305341-Humans,
pubmed-meshheading:20305341-Male,
pubmed-meshheading:20305341-Microarray Analysis,
pubmed-meshheading:20305341-Middle Aged,
pubmed-meshheading:20305341-Proto-Oncogene Proteins c-kit,
pubmed-meshheading:20305341-Receptors, Progesterone,
pubmed-meshheading:20305341-Recurrence,
pubmed-meshheading:20305341-Risk Factors,
pubmed-meshheading:20305341-Survival Rate
|
pubmed:year |
2010
|
pubmed:articleTitle |
Evaluation of estrogen receptor alpha, estrogen receptor beta, progesterone receptor, and cKIT expression in desmoids tumors and their role in determining treatment options.
|
pubmed:affiliation |
Department of Anatomic Pathology, Cancer Hospital A.C. Camargo, São Paulo, Brasil;
|
pubmed:publicationType |
Journal Article
|